Safety of REL-1017 for Major Depressive Disorder
Study sponsor: Relmada Therapeutics, Inc. · RLMD
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-07-27Actual
Enrollment · participants627Actual
Source updated2025-02-11Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.